OBJECTIVE: In obese men, sex hormone-binding globulin (SHBG) as well as total testosterone (TT) levels are decreased. Data concerning serum free testosterone (FT) levels in obese men are discordant. FT levels are decreased in only some morbidly obese men, consistent with an impairment of the feedback regulatory mechanism. In this study we aimed to verify serum levels of TT and FT in were studied before and after 6 months of a low energy diet (1200 kcaladay). Every patient received a therapeutic prescription of dexfen¯ur-amine (15 mg b.i.d.) that was maintained for 6 months. SUBJECTS: Thirty-seven obese men and 20 normal weight men. MEASUREMENTS: Serum sex hormones (TT and FT), serum luteinizing hormone (LH) and insulin were analyzed by RIA assays. Plasma insulin levels, serum TT, FT and LH concentrations were obtained before and after weight loss. RESULTS: Moderately obese men (BMI 32.3 AE 1.9 kgam 2 ) presented signi®cantly decreased TT levels (390 AE 120 ngadl) as well as FT (mean AE s.d. : 16.0 AE 4.8 pgaml) as compared with normal controls. FT serum levels had a signi®cant and negative correlation with body mass index (BMI), whereas for TT concentrations this correlation was not signi®cant. Serum LH concentrations (4.5 AE 2.9 mlUaml) were normal. Insulin levels were elevated in all patients (46.3 AE 30.1 m mUaml). After weight loss there was a signi®cant (P`0.01) increase in TT, FT and LH levels, whereas insulin concentrations signi®cantly decreased. In massively obese men (BMI 43.0 AE 6.7 kgam 2 ), TT (320 AE 110 ngadl), FT (11.0 AE 2.1 pgaml) and LH (3.1 AE 1.3 mlUaml) were decreased and signi®cantly lower as compared with the previous group and normal controls. As expected, after weight loss TT, FT and LH levels increased signi®cantly while insulin concentrations decreased. CONCLUSIONS: We concluded that FT levels are dependent on the degree of obesity, massively obese men (BMI ! 35.1 kgam 2 ) being considered as candidates for consistently low FT levels. A functional decrease of LH pulse amplitude and serum LH levels as well as a possible negative action of excess of circulating leptin on the steroidogenesis may be related to the decreased androgens levels in massively obese men.
Introduction
In male subjects total testosterone blood concentrations are inversely correlated with body weight. 1 ± 3 Therefore, obese male subjects have lower mean total testosterone (TT) concentrations than normal weight healthy controls. 4 ± 7 Several factors have been proposed to account for the decreased plasma TT levels in obese patients, including decreased sex hormonebinding globulin (SHBG) synthesis 8 and decreased pituitary gonadotropin secretion and pulse amplitude. 9 Free testosterone (FT) levels seem to be less affected than TT concentrations. Whereas some researchers report normal FT in obese subjects, 4 ± 6 others 9 ± 12 report decreased FT levels. As previously proposed by Giagulli et al, 2 lower TT levels in the absence of decreased FT concentrations suggest that the decrease is uniquely the consequence of the reduced SHBG-binding capacity, whereas a decrease in FT levels suggests a functional impairment at pituitary level with decreased output of gonadotropins. Reduction of luteinizing hormone (LH) pulse amplitude seems to occur only in massively obese men. 9 On the other hand, weight-loss SHBG levels increased, showing a negative linear correlation with body mass index (BMI). 8, 13 Moreover, hyperinsulinemia, frequently found in obese men, has an inhibitory effect on SHBG synthesis. 14 Thus, the decrease in plasma insulin levels occurring after weight loss may lead to increased SHBG levels 15 and consequently, to higher serum concentrations of TT.
We felt that studying the effect of weight loss on serum TT, FT, LH and insulin concentrations might provide in vivo evidence to support the proposed explanations for the pathogenesis of decreased androgen levels in obese men.
Patients and methods

Patients
A cohort of unselected obese men (n 37), aged 20 ± 68 y, entered in this study. They were, subsequently, divided into two groups: group 1 (n 14, mean AE s. ; group 2 (n 23, mean age 39 AE 8.5 y, range 20 ± 49 y old) with BMI ! 35.1 kgam 2 . Thyroid, liver and kidney functions were normal as assessed by routine clinical and laboratory tests. None was overtly diabetic. Two patients had moderate hypertension and were prescribed diuretics. At basal (control) conditions the patients were examined, the BMI established, and blood was drawn for plasma insulin, serum TT, FT, LH and follicle-stimulating hormone (FSH). The patients were instructed to follow a low energy diet (1200 kcaladay), to exercise within the limits of their capacity and to return for consultation every 2 months. All patients received a prescription for dexfen¯uramine (15 mg b.i.d.) that was maintained for 6 months. There were no major side effects with this medication except for somnolence (12%) and dry mouth (7%). After 6 months the laboratory tests were repeated as above, after dexfenuramine was withdrawn. The clinical data were recorded (weight loss, BMI, blood pressure) and compared with the basal levels.
Controls
Twenty healthy normal weight men, aged 24 ± 46 y (meanAE s.d., 36.7 AE 9.8 y old) with a BMÌ 25 kgam 2 , without any signs or symptoms related to the endocrine system (more speci®cally to the gonadal function) were selected as normal controls. Routine biochemical tests, thyroid function tests, gonadotropins, serum insulin and TaF testosterone levels were normal.
Methods
TT and FT were measured by RIA assays (Diagnostic Systems Laboratories Inc., Webster, TX, USA). Their average sensitivities were 10 ngadl and 0.18 pgaml and the within-run and between-run coef®cients of variation (CVs) were 8.3 and 7.7 and 6.2 and 8.9%, respectively. The normal ranges were: TT 280 ± 880 ngadl; FT 11.5 ± 40.1 pgaml. Insulin was measured by RIA (Diagnostic Systems Laboratories Inc., Webster, TX, USA) with a sensitivity of 1.5 mUaml and CVs of 8.5 and 9.9%, respectively. The normal range was 2.1 ± 30.8 mUaml.
(LH was measured by FIA (AutoDELFIA hLH, Wallac Oy, Turku, Finland) with sensitivity limit of 0.15 mUaml and CVs of 6.6 and 7.3%, respectively. The normal range was 1.0 ± 8.4 mUaml.
Statistical analysis
The signi®cance of differences in serum hormone concentrations pre-and post-treatment of obese patients was assessed using nonparametrical statistical methods (Wilcoxon rank sum test). Linear regression between two variables was calculated with the respective 95% con®dence interval for the regression line.
For comparison of data between the obese group and control group, we used the Kruskal ± Wallis test and Wilcoxon rank sum test, including the Bonferroni correction. The`Prism2 Graph Pad' software program, version 2.0 was used for the statistical analysis.
Results
The results are shown in Figures 1 and 2 and Tables 1  and 2 . Blood sampling was collected at baseline and 2 weeks after dexfen¯uramine was withdrawn at the end of the 6 month period of treatment. In group 1, the mean AE s.d. weight of 96.4 AE 10.1 kg declined to 80.5 AE 11.2 kg at the end of 6 months of dieting and medication (range 3.2 ± 15.0 kg of weight loss). As a consequence, the BMI fell from 32.3AE 1.9 to 29.4 AE 2.2 kgam 2 . There was a signi®cant decrease in total cholesterol, LDL-cholesterol and triglycerides levels (results not shown). Serum insulin signi®cantly (P`0.05) decreased from 46.3AE 30.1 to 19.6 AE 9.9 mUaml. There was no signi®cant correlation between serum TT, FT and insulin, both before and after weight loss. Serum LH changed from a basal mean AE s.d. level of 4.5 AE 2.9 mUaml to 6.1 AE 1.9 mUaml (not statistically signi®cant). As expected there was a signi®cant (P`0.01) increase in TT and FT levels ( Table 1) . As shown in Table 1 , all parameters for group 1 (except LH) had mean AE s.d. values that differed signi®cantly from normal controls, before and after weight loss.
In group 2 of obese men, the mean AE s.d. basal weight of 131.0AE 25.6 kg declined to 120.0AE 21.0 kg after 6 months of dieting and medication (range 4.4 ± 28.0 kg). As shown in Table 2 a corresponding signi®cant (P`0.05) decline in BMI was observed. Serum insulin levels signi®cantly (P`0.05) decreased from 58.1 AE 23.0 to 25.4AE 7.3 mUaml. Serum LH signi®cantly (P`0.05) increased from 3.1 AE 1.3 mlaml to 5.0 AE 2.2 mlaml. As in group 1, both TT and FT levels signi®cantly (P`0.01) increased after weight loss (Table 2, Figure 1 ). It is worth mentioning that group 2 patients with higher Total serum testosterone had no signi®cant correlation with BMI (kgam 2 ) whereas free testosterone serum levels exhibited a negative and signi®cant correlation BMI (r 0.52, P`0.01). Hypoandrogenism in massive obesity N Lima et al BMI had lower levels of serum TT both at basal and after 6 months of dieting as compared with group 1 patients. As in the previous group the mean AE s.d. values for the various parameters in these patients differed signi®cantly from normal controls, before and after weight loss ( Table 2 ). The variations of serum FT concentrations are shown in Figure 1 . Note that patients with BMI ! 35.1 kgam 2 had signi®cantly (P`0.01) lower serum mean FT levels as compared with group 1 patients (BMI`35 kgam 2 ), in basal conditions. After weight loss (at 6 months), both groups had a signi®cantly (P`0.01) higher level of serum FT. Again, group 2 patients had a lower mean concentration of serum FT in comparison to group 1 subjects (Figure 1 ). When both groups were considered together (n 37), FT serum levels plotted against basal BMI exhibited a signi®cant and negative correlation with BMI (r 0.52 (P`0.01)), whereas TT serum concentrations showed no signi®cant correlation with BMI ( Figure 2 ).
Discussion
The results of this study con®rm that, in obese men, total serum testosterone levels are signi®cantly decreased as compared to those in normal men of similar age. A previous study 15 has indicated an inverse linear correlation of serum SHBG concentration with BMI and a direct linear correlation of plasma insulin with BMI. An inhibitory effect of insulin on SHBG synthesis has been demonstrated in vitro in human hepatoma cells 14 and the inhibitory effect may be involved in vivo. The reduced serum TT in men is linked with a decrease in SHBG levels and this may be connected to the inhibitory effect induced by high plasma insulin concentrations. In the present report the serum mean TT decreased levels observed in the obese men were not signi®cantly different in moderately obese men as compared to severely obese men. Moreover, plasma mean insulin concentrations were not statistically different in the two groups of patients. However, moderately obese men had a signi®cantly (P`0.01) higher mean serum FT as compared with massively obese men. This may be related to a low serum basal LH level as well as a lower LH pulse amplitude as found in severely obese men, implying an impairment of the gonadostat. 2 Very recently, Isidori et al 16 have demonstrated that excess circulating leptin may be an important contributor to the reduced androgens serum levels in male obesity. Their data have indicated that leptin has negative actions on steroidogenesis that are mediated by speci®c receptors in the Leydig cells. After weight loss, at 6 months, we observed an increase in serum TT, FT and LH that correlated with a decrease in plasma insulin concentrations. It is accepted that weight loss per se would increase SHBG levels. Strain et al 8 have reported that, during weight loss, serum SHBG levels increase at an average slope of 0.43 nmolal per unit decrease in BMI. Thus, after weight loss, the increased serum TT concentrations may be due to a dual mechanism: (1) an increased binding capacity of SHBG; and (2) an increased amplitude of spontaneous LH pulses. The decreased serum FT levels found only in massively obese men suggest a functional impairment of the gonadotrophic stimulation of the Leydig cells. The resulting hypoandrogenism is well documented in all patients but, surprisingly, with little clinical signi®cance. Only two patients referred to a decrease in libido and limited sexual activity. All other patients had a normal sexual behavior and reported no difference before and after weight loss. It is conceivable that the decrease in serum FT concentrations, in some patients well below the normal range, is still within physiological levels, without any re¯ection in the sexual drive.
In conclusion, we have demonstrated that severely obese men BMI above 35.1 kgam 2 have reduced serum FT levels that improved after weight loss. Moreover, the increased plasma insulin concentrations returned to almost normal levels, probably leading to normalization of SHBG levels and normal serum TT levels after weight loss.
